biotech · Attention Deficit Hyperactivity Disorder · Vascular Ehlers-Danlos Syndrome · AYTU
AYTU BIOPHARMA
AYTU BIOPHARMA, INC
Aytu BioPharma is a biotech organization headquartered in Denver, USA. It trades on NYSE under ticker AYTU. Primary therapeutic focus areas include Attention Deficit Hyperactivity Disorder, Vascular Ehlers-Danlos Syndrom
Company details
- Status
- Public
- HQ
- Denver, USA
- Founded
- 2015
- Employees
- 105
- Programs
- 3
- Drugs
- 5
- Patents
- 4
Antioxidant
Unknown · other · Compare the sORP Rate in Sperm Samples, Obtained by the Mioxsys System, Before and After 2.5 Months Antioxidant Men Supplements Treatment (Fertybiotic Man)
Antioxidant for Compare the sORP Rate in Sperm Samples, Obtained by the Mioxsys System, Before and After 2.5 Months Antioxidant Men Supplements Treatment (Fertybiotic Man) is a Unknown program (other) at AYTU BIOPHARMA, INC with 1 ClinicalTrials.gov record(s).
Internal code 1708-BIO-088-MM
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- AYTU BIOPHARMA, INC
- Phase
- Unknown
- Modality
- other
- Indication
- Compare the sORP Rate in Sperm Samples, Obtained by the Mioxsys System, Before and After 2.5 Months Antioxidant Men Supplements Treatment (Fertybiotic Man)
- Status
- terminated
- Trials
- 1